反应详情

Compound 14 was prepared from 4-[4-(4-fluorophenyl)-2-methyl-1-piperidin-4-yl-1H-imidazol-5-yl]pyrimidine (C31) according to the general procedure for the synthesis of 4-{4-(4-fluorophenyl)-1-[1-(isoxazol-3-ylmethyl)piperidin-4-yl]-1H-imidazol-5-yl}-N-methylpyrimidin-2-amine (5) in Example 5, except that extractions were carried out with dichloromethane, and the eluant employed for chromatography was 5% methanol in dichloromethane. The product was obtained as a solid. Yield: 10 mg, 0.024 mmol, 23%. LCMS m/z 419.6 (M+1). 1H NMR (400 MHz, CDCl3) δ 1.95-2.00 (m, 2H), 2.15 (ddd, J=11.8, 11.8, 2.0 Hz, 2H), 2.27-2.37 (m, 2H), 2.65 (s, 3H), 3.01 (br d, J=11.6 Hz, 2H), 3.67 (s, 2H), 4.48 (tt, J=12.4, 4.0 Hz, 1H), 6.39 (d, J=1.7 Hz, 1H), 6.96 (dd, J=8.8, 8.8 Hz, 2H), 7.12 (dd, J=5.3, 1.5 Hz, 1H), 7.29 (dd, J=8.8, 5.4 Hz, 2H), 8.38 (d, J=1.7 Hz, 1H), 8.55 (d, J=5.3 Hz, 1H), 9.30 (d, J=1.4 Hz, 1H).

1. customThe product was obtained as a solid